Oxford, UK (June 15, 2016)
Bio-Rad is pleased to announce the company has changed the name of “AbD Serotec, a Bio-Rad Company” to “Bio-Rad”.
There is a new name and website URL, but these are the only changes that customers will experience. It’s business as usual for ordering antibodies and there will be no change required to contracts and service agreements.
The portfolio of anti-biotherapeutic antibodies for bioanalytical assay development will continue to expand and the custom recombinant antibody generation service provides antibodies to customers’ specialized targets.
We will carry on working with our clients for long-term success, and can be trusted to provide critical reagents for drug development assays and diagnostic kits.
Contact us to discuss your bioanalytical assay needs with our antibody specialists.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,600 people worldwide and had revenues exceeding $2.1 billion in 2014. For more information, please visit www.bio-rad.com.